FDA Under Temporary New Leadership as Senate Considers Nominee
November 5, 2019
Mari Serebrov
BioWorld
Axinn partner Chad Landmon was quoted in the BioWorld article, "FDA Under Temporary New Leadership as Senate Considers Nominee."
Click here to access the article. A subscription is required.